Regend Therapeutics raised $50.6M Series C venture round.
Series C funding round for Regend Therapeutics raising $51M in February 2026
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Private Equity | — |
| Private Equity | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$50.6M
Top Valuation
-
Regend Therapeutics raised $50.6M in a Series C round.
The round was announced on 02/11/26.
Series C funding round for Regend Therapeutics raising $51M in February 2026